Literature DB >> 34743291

Analysis of inflammation-related microRNA expression in patients with ankylosing spondylitis.

Huiling Tan1, Ruyu Ren1, Junlong Zhang1, Zhuochun Huang1, Qian Niu1, Bin Yang2.   

Abstract

Ankylosing spondylitis (AS) is a complex genetic disease characterized by axial skeletal inflammation. Available scientific evidence suggests that a relationship may exist between miRNA expression levels and the pathogenesis of AS. This study investigated the clinical diagnostic value of miR-146a, miR-15a, miR-20a, miR-125a-3p, miR-125a-5p, miR-125b-5p, miR-148a, miR-149a, miR-499, and miR-155a in AS. A total of 44 AS patients and 56 healthy controls (HCs) were included in the study. MiRNA expression levels were detected using fluorescence quantitative PCR (qPCR). Results showed that the expression levels of miR-146a, miR-125a-3p, miR-125a-5p, miR-125b-5p, and miR-155a decreased, whereas miR-499a expression increased significantly in AS patients compared to that in the controls. Logistic regression analysis with receiver operating characteristic (ROC) curves showed that combined miR-146a/miR-125a-5p/miR-125b-5p/miR-499a/miR-155a (area under curve [AUC] = 0.824, 95% confidence interval [CI] = 0.727-0.921) had high sensitivity and specificity for AS diagnosis. C-reactive protein (CRP) levels were positively correlated with the expression of miR-125a-5p (rs = 0.438, p = 0.005) and miR-155a (rs = 0.414, p = 0.006), which indicates that miR-125a-5p and miR-155a can perhaps aggravate AS-induced inflammation. Our findings suggest the association of miR-125a-5p and miR-155a with disease activity in AS patients. Furthermore, miR-146a, miR-125a-5p, miR-125b-5p, miR-499a, and miR-155a could have potential diagnostic value in AS.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Ankylosing spondylitis; Diagnosis; Inflammatory factors; ROC curve; miRNA

Mesh:

Substances:

Year:  2021        PMID: 34743291     DOI: 10.1007/s12026-021-09249-6

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  3 in total

Review 1.  MicroRNA in breast cancer: The association with BRCA1/2.

Authors:  Nina Petrovic; Radoslav Davidovic; Vladan Bajic; Milan Obradovic; R Esma Isenovic
Journal:  Cancer Biomark       Date:  2017       Impact factor: 4.388

2.  Expression of MicroRNA-146a in peripheral blood mononuclear cells in patients with systemic lupus erythematosus.

Authors:  Wang Hai-yan; Li Yang; Chen Mei-hong; Zhang Hui
Journal:  Zhongguo Yi Xue Ke Xue Yuan Xue Bao       Date:  2011-04

Review 3.  Ankylosing spondylitis: an update.

Authors:  Vera Golder; Lionel Schachna
Journal:  Aust Fam Physician       Date:  2013-11
  3 in total
  2 in total

1.  miR-148a-3p facilitates osteogenic differentiation of fibroblasts in ankylosing spondylitis by activating the Wnt pathway and targeting DKK1.

Authors:  Wenbo Sheng; Haitao Jiang; Hantao Yuan; Sibo Li
Journal:  Exp Ther Med       Date:  2022-04-01       Impact factor: 2.751

2.  miR-150-5p inhibits osteogenic differentiation of fibroblasts in ankylosing spondylitis by targeting VDR.

Authors:  Yuan Li; Wufang Qi; Yuquan Shi
Journal:  Exp Ther Med       Date:  2022-02-15       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.